Actavis, Inc. (NYSE: ACT), a global specialty pharmaceutical leader, today confirmed that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE